Interestingly, direct blockade of downstream JAK3 activity with anti-γc antibody could suppress γc cytokine-induced NK cell activation but maintains immunity against tumor cells, suggesting that antibody might offer a safer strategy to treat NK cell-mediated autoimmune diseases. Here, GC is linked to autoimmune disease.